Litaty mbatchi
Web28 apr. 2024 · In line with Mbatchi et al., we found only two statistically significant results: a decrease of SN-38 AUC (Wilcoxon, p = 0.0069) and a decrease of the biliary index of … WebMarie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Christophe Beroud, Litaty Mbatchi, André van Kuilenburg, Christine Bobin-Dubigeon, Fabienne Thomas, Etienne Chatelut, Jean-Louis Merlin, Frédéric Pinguet, Christophe Ferrand, Judith Meijer, Alexandre Evrard, Laurence Llorca, Gilles Romieu, Philippe Follana, Thomas Bachelot, Loic …
Litaty mbatchi
Did you know?
WebAlexandre Evrard 1 , Litaty Mbatchi. Affiliation 1 Biochemistry and Toxicology Department, University Hospital of Nimes, Place du Professeur Robert Debre, 30029 Nimes Cedex 9, … Web29 nov. 2024 · Litaty C. Mbatchi. UQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia. Steven C. Wallis, Jeffrey Lipman & Jason A. …
WebLitaty C. Mbatchi What is known and objective: Sunitinib pharmacokinetics can be influenced by the physio-pathological conditions of individual patients. Therapeutic drug monitoring (TDM) helps... Web1 aug. 2012 · A series of nitrated 2-substituted-quinolines was synthesized and evaluated in vitro toward Leishmania donovani promastigotes. In parallel, the in vitro cytotoxicity of these molecules was assessed on the murine J774 and human HepG2 cell lines. Thus, a very promising antileishmanial hit molecule was identified (compound 21), displaying an IC 50 …
WebLitaty Mbatchi's 25 research works with 290 citations and 1,629 reads, including: Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast … Web1 sep. 2011 · @article{CasteraDucros2011TargetingTH, title={Targeting the human malaria parasite Plasmodium falciparum: in vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline series.}, author={Caroline Castera-Ducros and Nadine Azas and Pierre Verhaeghe and S{\'e}bastien Hutter and Philippe Garrigue and …
Web11 apr. 2024 · Mbatchi L 3, Evrard A 3, Jacot W 1. Author information. Affiliations. 11 authors. 1. Institut du Cancer de ... Stéphane Pouderoux, 1, 2 Marie Viala, 1 Gerald Lossaint, 1 Chloé Gautier, 1 Caroline Mollevi, 1 Matthieu Gracia, 2 Celine Gongora, 2 Litaty Mbatchi, 2, 3, 4 Alexandre Evrard, 2, 3, 4 and William Jacot 1, 2 José ...
Web5 sep. 2024 · Author links open overlay panel Fanny Leenhardt a b c, Matthieu Gracia a c, Catherine Perrin d, Claudia Muracciole-Bich d, Bénédicte Marion d, Celine Roques d, Marie Alexandre e, Nelly Firmin c e, Stephane Pouderoux e, Litaty Mbatchi a c f, Celine Gongora c, William Jacot c e, Alexandre Evrard a c f chattooga chamber of commerceWebPalbociclib is a good candidate for therapeutic drug monitoring (TDM) due to its narrow therapeutic range and frequency of toxicities, particularly high-grade neutropenia. In this prospective, bicentric clinical trial, we evaluated the palbociclib exposure–toxicity relationship and determined the relevant sources of palbociclib pharmacokinetic … customize your own floor matsWeb23 jun. 2011 · From the promising results we previously obtained in quinazoline series and to complete the evaluation of the in vitro antiplasmodial activity of original 2-trichloromethylquinazolines, we synthesized new quinazolines possessing a variously substituted phenoxy group at position 4 through a simple and efficient two-step-synthesis … customize your own fidget spinner to keepWebProduct Description. BAY-8002 is a novel potent, selective, orally available monocarboxylate transporter 1 (MCT1) inhibitor (Kd=7.9 nM), which inhibits cellular lactate uptake in DLD-1 cells with IC50 of 85 nM. customize your own flasksWeb4 jul. 2024 · Temsirolimus is a mammalian target of rapamycin (mTOR) inhibitor that exhibits antitumor activity in renal cell carcinoma and mantle cell lymphoma. The metabolism of temsirolimus and its active metabolite sirolimus mainly depends on cytochrome P450 3A4/5 (CYP3A4/A5) and the ABCB1 transporter. Differently from sirolimus, no … chattooga and floyd county georgiaWeb1 feb. 2024 · Hai L. Ba, L. Mbatchi, +5 authorsS. Salas Published1 February 2024 Medicine, Biology Pharmacogenomics A 53-year-old woman with papillary thyroid cancer treated with 800 mg sorafenib therapy rapidly experienced grade 3 toxicities. chattooga county board of educationWebImpact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study customize your own fitted cap